Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C C Mok

Showing results (71-80 of 101) with videos related to

Pageof 11
Sort By:
Lupus|October 12, 2013
Effect of raloxifene on disease activity and vascular biomarkers in patients with systemic lupus erythematosus: subgroup analysis of a double-blind randomized controlled trialC C Mok, Shirley K Y Ying, K M Ma, et al.
The Journal of Endocrinology|September 1, 1973
Hypothalamic stimulation of insulin releaseJ M Martin, C C Mok, J Penfold, et al.
Rheumatology (Oxford, England)|October 20, 2005
Outcome of protein-losing gastroenteropathy in systemic lupus erythematosus treated with prednisolone and azathioprineC C Mok, K Y Ying, A Mak, et al.
Rheumatology (Oxford, England)|April 6, 2006
Adrenomedullin--a potential disease activity marker and suppressor of nephritis activity in systemic lupus erythematosusA Mak, B M Y Cheung, C C Mok, et al.
Arthritis and Rheumatism|March 11, 2011
Life expectancy, standardized mortality ratios, and causes of death in six rheumatic diseases in Hong Kong, ChinaC C Mok, C L Kwok, L Y Ho, et al.
Lupus|November 26, 2008
Risk and predictors of work disability in Chinese patients with systemic lupus erythematosusC C Mok, M Y Cheung, L Y Ho, et al.
Rheumatology (Oxford, England)|May 19, 2000
A prospective study of survival and prognostic indicators of systemic lupus erythematosus in a southern Chinese populationC C Mok, K W Lee, C T Ho, et al.
Scandinavian Journal of Rheumatology|November 11, 2008
Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2-year prospective studyC C Mok, L Y Ho, M Y Cheung, et al.
Scandinavian Journal of Rheumatology|August 15, 2015
Effect of golimumab and pamidronate on clinical efficacy and MRI inflammation in axial spondyloarthritis: a 48-week open randomized trialC C Mok, O C Li, K L Chan, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 27, 2007
Risedronate for prevention of bone mineral density loss in patients receiving high-dose glucocorticoids: a randomized double-blind placebo-controlled trialC C Mok, K H Tong, C H To, et al.
Pageof 11

Showing results (71-80 of 101) with videos related to

Sort By:
Pageof 11
Lupus|October 12, 2013
Effect of raloxifene on disease activity and vascular biomarkers in patients with systemic lupus erythematosus: subgroup analysis of a double-blind randomized controlled trialC C Mok, Shirley K Y Ying, K M Ma, et al.
The Journal of Endocrinology|September 1, 1973
Hypothalamic stimulation of insulin releaseJ M Martin, C C Mok, J Penfold, et al.
Rheumatology (Oxford, England)|October 20, 2005
Outcome of protein-losing gastroenteropathy in systemic lupus erythematosus treated with prednisolone and azathioprineC C Mok, K Y Ying, A Mak, et al.
Rheumatology (Oxford, England)|April 6, 2006
Adrenomedullin--a potential disease activity marker and suppressor of nephritis activity in systemic lupus erythematosusA Mak, B M Y Cheung, C C Mok, et al.
Arthritis and Rheumatism|March 11, 2011
Life expectancy, standardized mortality ratios, and causes of death in six rheumatic diseases in Hong Kong, ChinaC C Mok, C L Kwok, L Y Ho, et al.
Lupus|November 26, 2008
Risk and predictors of work disability in Chinese patients with systemic lupus erythematosusC C Mok, M Y Cheung, L Y Ho, et al.
Rheumatology (Oxford, England)|May 19, 2000
A prospective study of survival and prognostic indicators of systemic lupus erythematosus in a southern Chinese populationC C Mok, K W Lee, C T Ho, et al.
Scandinavian Journal of Rheumatology|November 11, 2008
Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2-year prospective studyC C Mok, L Y Ho, M Y Cheung, et al.
Scandinavian Journal of Rheumatology|August 15, 2015
Effect of golimumab and pamidronate on clinical efficacy and MRI inflammation in axial spondyloarthritis: a 48-week open randomized trialC C Mok, O C Li, K L Chan, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 27, 2007
Risedronate for prevention of bone mineral density loss in patients receiving high-dose glucocorticoids: a randomized double-blind placebo-controlled trialC C Mok, K H Tong, C H To, et al.
Pageof 11